drugset / Trial / NCT01504139

The Luteal Phase After GnRHa Trigger - a Proof of Concept Study

NCT01504139

Phase 4 Completed 93 enrolled Regionshospitalet Viborg, Skive
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate levels of progesterone in the luteal phase after various stimulations in the follicular phase and treatment with GnRH antagonist protocol followed by GnRHagonist as induction of ovulation.

Timeline

Start
2012-01
Primary completion
2014-04
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estradiol Other / unclassified
Subject Luveris Protein / enzyme biologic
Subject Ovidrel Protein / enzyme biologic 125 iu
Comparator Progesterone Other / unclassified Intrathecal

Indications